Evidence map›Paper›PMID 30919879›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Clinical Correlates of Human Immunodeficiency Virus-1 (HIV-1) DNA and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With Sustained Virologic Suppression for at Least 5 Years.

Ari Bitnun, Doris G Ransy, Jason Brophy, Fatima Kakkar, Michael Hawkes, Lindy Samson, Bayader Annabi, Amélie Pagliuzza, Jacob-Adams Morand, Laura Sauve and 10 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  3. Article
  4. Article
  5. Article
  6. Demographics of Youth With Newly Diagnosed Acute/Recent HIV Infection in Adolescent Trials Network 147: Early Treatment of Acute HIV Infection.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 3 countries.

Ari BitnunDepartment of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario.
Doris G RansyCentre de Recherche du Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, Quebec.
Jason BrophyDepartment of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ontario.
Fatima KakkarDepartment of Pediatrics, CHU Sainte-Justine, Université de Montréal, Quebec.
Michael HawkesDepartment of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton.
Lindy SamsonDepartment of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ontario.
Bayader AnnabiCentre de Recherche du Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, Quebec.
Amélie PagliuzzaCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec.
Jacob-Adams MorandCentre de Recherche du Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, Quebec.
Laura SauveOak Tree Clinic, Women's Hospital and Health Centre of British Columbia, Department of Pediatrics, University of British Columbia, Vancouver.
Nicolas ChomontDepartment of Microbiology, Infectiology & Immunology, Université de Montréal, Quebec.
Stephanie LavoieNational Human Immunodeficiency Virus (HIV) & Retrovirology Laboratories, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
John KimNational Human Immunodeficiency Virus (HIV) & Retrovirology Laboratories, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Paul SandstromNational Human Immunodeficiency Virus (HIV) & Retrovirology Laboratories, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Paul A WenderDepartment of Chemistry and Department of Chemical and Systems Biology, Stanford University, California.
Terry LeeCanadian Institutes of Health Research Canadian HIV Trials Network, Vancouver, British Columbia.
Joel SingerCanadian Institutes of Health Research Canadian HIV Trials Network, Vancouver, British Columbia.
Stanley E ReadDepartment of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario.
Hugo SoudeynsCentre de Recherche du Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, Quebec.
Early Pediatric Initiation Canada Child Cure Cohort (EPIC4) Research Group
Public Health Agency of Canada · CACanadian Institutes of Health Research · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversité de Montréal · CAGreat Ormond Street Hospital · GBCentre Hospitalier de l’Université de Montréal · CAChildren's Hospital of Eastern Ontario · CAStanford University · USUniversity of Ottawa · CAB.C. Women's Hospital & Health Centre · CAHospital for Sick Children · CAStollery Children's Hospital · CAUniversity College London · GBUniversity of Alberta · CAUniversity of British Columbia · CA

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
SYNTHETIC STUDIES RELATED TO CANCER RESEARCH/TREATMENTR01CA031845 · NCI · STANFORD UNIVERSITY · PI PAUL Anthony WENDER · 1985 to 2026
$6.9M
HIV latency reversal through novel, potent PKC modulatorsR01AI124743 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WENDER, PAUL ANTHONY, ZACK, JEROME A. · 2016 to 2020
$3.3M
CIHRNCI NIH HHS R01 CA031845NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI124743
6 · The paper itself

Abstract

backgroundThe Early Pediatric Initiation Canada Child Cure Cohort (EPIC4) study is a prospective, multicenter, Canadian cohort study investigating human immunodeficiency virus-1 (HIV-1) reservoirs, chronic inflammation, and immune responses in children with perinatally acquired HIV-1 infection. The focus of this report is HIV-1 reservoirs and correlates in the peripheral blood of children who achieved sustained virologic suppression (SVS) for ≥5 years.

methodsHIV-1 reservoirs were determined by measuring HIV-1 DNA in peripheral blood mononuclear cells and inducible cell-free HIV-1 RNA in CD4+ T-cells by a prostratin analogue stimulation assay. HIV serology was quantified by signal-to-cutoff ratio (S/CO).

resultsOf 228 enrolled participants, 69 achieved SVS for ≥5 years. HIV-1 DNA, inducible cell-free HIV-1 RNA, and S/COs correlated directly with the age of effective combination antiretroviral therapy (cART) initiation (P < .001, P = .036, and P < .001, respectively) and age when SVS was achieved (P = .002, P = .038, and P < .001, respectively) and inversely with the proportion of life spent on effective cART (P < .001, P = .01, and P < .001, respectively) and proportion of life spent with SVS (P < .001, P = .079, and P < .001, respectively). Inducible cell-free HIV-1 RNA correlated with HIV-1 DNA, most particularly in children with SVS, without virologic blips, that was achieved with the first cART regimen initiated prior to 6 months of age (rho = 0.74; P = .037) or later (rho = 0.87; P < .001). S/COs correlated with HIV-1 DNA (P = .003), but less so with inducible cell-free HIV-1 RNA (P = .09).

conclusionsThe prostratin analogue stimulation assay, with its lower blood volume requirement, could be a valuable method for evaluating inducible HIV-1 reservoirs in children. Standard commercial HIV serology may be a practical initial indirect measure of reservoir size in the peripheral blood of children with perinatally acquired HIV-1 infection.

Indexed as

HIV-1HIV InfectionsCanadaChildCohort StudiesHumansLeukocytes, MononuclearProspective StudiesRNAViral LoadRNAchildHIV-1 DNAinducible RNAprostratin analoguereservoir

Identifiers

PMID30919879
PMCPMC7319270
OpenAlexW2927404510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.